Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Doyle

Showing results (821-830 of 848) with videos related to

Pageof 85
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2021
Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves RecoveryThuy-Vi V Nguyen, Rachel H Crumpacker, Kylie E Calderon, et al.
Ethnicity & Disease|November 2, 2005
Diabetes management by residents in training in a municipal hospital primary care site (IPCAAD 2)Christopher D Miller, David C Ziemer, Joyce P Doyle, et al.
Experimental Neurology|July 28, 2020
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesiaMitchell J Bartlett, Andrew J Flores, Tony Ye, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
The Novel Chimeric Multi-Agonist Peptide (GEP44) Reduces Energy Intake and Body Weight in Male and Female Diet-Induced Obese Mice in a Glucagon-Like Peptide-1 Receptor-Dependent MannerJames E Blevins, Mackenzie K Honeycutt, Jared D Slattery, et al.
Frontiers in Endocrinology|August 6, 2024
The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-dependent mannerJames E Blevins, Mackenzie K Honeycutt, Jared D Slattery, et al.
Diabetes, Obesity & Metabolism|January 13, 2018
A vitamin B12 conjugate of exendin-4 improves glucose tolerance without associated nausea or hypophagia in rodentsElizabeth G Mietlicki-Baase, Claudia G Liberini, Jayme L Workinger, et al.
Mbio|April 14, 2022
Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever VirusMichael P Doyle, Joseph R Genualdi, Adam L Bailey, et al.
Pharmaceutica Acta Helvetiae|May 17, 2000
CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacologyH Tecle, R D Schwarz, S D Barrett, et al.
Annals of the New York Academy of Sciences|July 19, 2001
Stem cell engraftment strategiesP J Quesenberry, F M Stewart, P Becker, et al.
Journal of Pain and Symptom Management|August 14, 2017
Palliative Care in Vietnam: Long-Term Partnerships Yield Increasing AccessEric L Krakauer, Dang Huy Quoc Thinh, Quach Thanh Khanh, et al.
Pageof 85

Showing results (821-830 of 848) with videos related to

Sort By:
Pageof 85
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2021
Post-Stroke Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Attenuates Chronic Changes in Brain Metabolism, Increases Neurotransmitter Levels, and Improves RecoveryThuy-Vi V Nguyen, Rachel H Crumpacker, Kylie E Calderon, et al.
Ethnicity & Disease|November 2, 2005
Diabetes management by residents in training in a municipal hospital primary care site (IPCAAD 2)Christopher D Miller, David C Ziemer, Joyce P Doyle, et al.
Experimental Neurology|July 28, 2020
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesiaMitchell J Bartlett, Andrew J Flores, Tony Ye, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
The Novel Chimeric Multi-Agonist Peptide (GEP44) Reduces Energy Intake and Body Weight in Male and Female Diet-Induced Obese Mice in a Glucagon-Like Peptide-1 Receptor-Dependent MannerJames E Blevins, Mackenzie K Honeycutt, Jared D Slattery, et al.
Frontiers in Endocrinology|August 6, 2024
The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-dependent mannerJames E Blevins, Mackenzie K Honeycutt, Jared D Slattery, et al.
Diabetes, Obesity & Metabolism|January 13, 2018
A vitamin B12 conjugate of exendin-4 improves glucose tolerance without associated nausea or hypophagia in rodentsElizabeth G Mietlicki-Baase, Claudia G Liberini, Jayme L Workinger, et al.
Mbio|April 14, 2022
Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever VirusMichael P Doyle, Joseph R Genualdi, Adam L Bailey, et al.
Pharmaceutica Acta Helvetiae|May 17, 2000
CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacologyH Tecle, R D Schwarz, S D Barrett, et al.
Annals of the New York Academy of Sciences|July 19, 2001
Stem cell engraftment strategiesP J Quesenberry, F M Stewart, P Becker, et al.
Journal of Pain and Symptom Management|August 14, 2017
Palliative Care in Vietnam: Long-Term Partnerships Yield Increasing AccessEric L Krakauer, Dang Huy Quoc Thinh, Quach Thanh Khanh, et al.
Pageof 85